FDA Import Refusals & Border Detention Tracker (OASIS)
Foreign manufacturers and shippers whose products were refused admission at U.S. ports of entry, resolved directly to their Facility Graph profiles.
OASIS-2026-88100 · 2026-01-19
Import Alert #66-10
Port: Los Angeles / Long Beach, CA
Jubilant HollisterStier LLC (USA)
FILTH / INSANITARY CONDITIONS (FD&C Act 402(a)(4))
The article appears to have been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth.
OASIS-2026-88101 · 2026-02-19
Import Alert #67-11
Port: Newark / NY, NJ
Shilpa Medicare Limited (India)
UNAPPROVED NEW DRUG / UNDECLARED INGREDIENT (FD&C Act 505(a))
The article appears to be a new drug without an approved New Drug Application (NDA) or ANDA.
OASIS-2026-88102 · 2026-03-19
Import Alert #68-12
Port: Houston, TX
Strides Pharma Science Limited (India)
ADULTERATED DIETARY SUPPLEMENT — CGMP (FD&C Act 402(g)(1))
The dietary supplement appears to have been prepared, packed, or held under conditions that do not meet Dietary Supplement CGMP regulations (21 CFR Part 111).
OASIS-2026-88103 · 2026-04-19
Import Alert #69-13
Port: Savannah, GA
Lonza Bend Inc. (USA)
MISBRANDED COSMETIC / COLOR ADDITIVE (FD&C Act 601(e))
The cosmetic product appears to bear or contain an unlisted color additive or lacks mandatory MoCRA responsible person labeling.
OASIS-2026-88104 · 2026-05-19
Import Alert #70-14
Port: Miami, FL
Emcure Pharmaceuticals Limited (India)
DEVICE LACKS 510(K) CLEARANCE (FD&C Act 510(k))
The medical device appears to lack required premarket notification 510(k) clearance or establishment registration.
OASIS-2026-88105 · 2026-06-19
Import Alert #71-15
Port: Los Angeles / Long Beach, CA
Mylan Laboratories Limited (India)
FILTH / INSANITARY CONDITIONS (FD&C Act 402(a)(4))
The article appears to have been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth.
OASIS-2026-88106 · 2026-07-19
Import Alert #72-16
Port: Newark / NY, NJ
Fresenius Kabi USA, LLC (USA)
UNAPPROVED NEW DRUG / UNDECLARED INGREDIENT (FD&C Act 505(a))
The article appears to be a new drug without an approved New Drug Application (NDA) or ANDA.
OASIS-2026-88107 · 2026-08-19
Import Alert #73-17
Port: Houston, TX
Alvotech Hf (Iceland)
ADULTERATED DIETARY SUPPLEMENT — CGMP (FD&C Act 402(g)(1))
The dietary supplement appears to have been prepared, packed, or held under conditions that do not meet Dietary Supplement CGMP regulations (21 CFR Part 111).
OASIS-2026-88108 · 2026-09-19
Import Alert #74-18
Port: Savannah, GA
Philips Oral Healthcare, LLC (USA)
MISBRANDED COSMETIC / COLOR ADDITIVE (FD&C Act 601(e))
The cosmetic product appears to bear or contain an unlisted color additive or lacks mandatory MoCRA responsible person labeling.
OASIS-2026-88109 · 2026-01-19
Import Alert #75-19
Port: Miami, FL
Perrigo New York, Inc. (USA)
DEVICE LACKS 510(K) CLEARANCE (FD&C Act 510(k))
The medical device appears to lack required premarket notification 510(k) clearance or establishment registration.
OASIS-2026-88110 · 2026-02-19
Import Alert #76-20
Port: Los Angeles / Long Beach, CA
Zydus Lifesciences Limited (India)
FILTH / INSANITARY CONDITIONS (FD&C Act 402(a)(4))
The article appears to have been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth.
OASIS-2026-88111 · 2026-03-19
Import Alert #77-21
Port: Newark / NY, NJ
Alkem Laboratories Limited (India)
UNAPPROVED NEW DRUG / UNDECLARED INGREDIENT (FD&C Act 505(a))
The article appears to be a new drug without an approved New Drug Application (NDA) or ANDA.
OASIS-2026-88112 · 2026-04-19
Import Alert #78-22
Port: Houston, TX
Zhejiang Huahai Pharmaceutical Co., Ltd. (China)
ADULTERATED DIETARY SUPPLEMENT — CGMP (FD&C Act 402(g)(1))
The dietary supplement appears to have been prepared, packed, or held under conditions that do not meet Dietary Supplement CGMP regulations (21 CFR Part 111).
OASIS-2026-88113 · 2026-05-19
Import Alert #79-23
Port: Savannah, GA
Jiangsu Hansoh Pharmaceutical Group Co Ltd. (China)
MISBRANDED COSMETIC / COLOR ADDITIVE (FD&C Act 601(e))
The cosmetic product appears to bear or contain an unlisted color additive or lacks mandatory MoCRA responsible person labeling.
OASIS-2026-88114 · 2026-06-19
Import Alert #80-24
Port: Miami, FL
BioLife Plasma Services, L.P. (USA)
DEVICE LACKS 510(K) CLEARANCE (FD&C Act 510(k))
The medical device appears to lack required premarket notification 510(k) clearance or establishment registration.
OASIS-2026-88115 · 2026-07-19
Import Alert #81-25
Port: Los Angeles / Long Beach, CA
Cliantha Research Limited (India)
FILTH / INSANITARY CONDITIONS (FD&C Act 402(a)(4))
The article appears to have been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth.
OASIS-2026-88116 · 2026-08-19
Import Alert #82-26
Port: Newark / NY, NJ
Novel Laboratories, Inc. d.b.a Lupin Somerset (USA)
UNAPPROVED NEW DRUG / UNDECLARED INGREDIENT (FD&C Act 505(a))
The article appears to be a new drug without an approved New Drug Application (NDA) or ANDA.
OASIS-2026-88117 · 2026-09-19
Import Alert #83-27
Port: Houston, TX
Lonza Biologics, Inc. (USA)
ADULTERATED DIETARY SUPPLEMENT — CGMP (FD&C Act 402(g)(1))
The dietary supplement appears to have been prepared, packed, or held under conditions that do not meet Dietary Supplement CGMP regulations (21 CFR Part 111).
OASIS-2026-88118 · 2026-01-19
Import Alert #84-28
Port: Savannah, GA
Biomat USA Inc (USA)
MISBRANDED COSMETIC / COLOR ADDITIVE (FD&C Act 601(e))
The cosmetic product appears to bear or contain an unlisted color additive or lacks mandatory MoCRA responsible person labeling.
OASIS-2026-88119 · 2026-02-19
Import Alert #85-29
Port: Miami, FL
Fujifilm Diosynth Biotechnologies USA Inc. (USA)
DEVICE LACKS 510(K) CLEARANCE (FD&C Act 510(k))
The medical device appears to lack required premarket notification 510(k) clearance or establishment registration.